Company Overview and News
Stop missing out on important events!
U.S. Attorney General Jeff Sessions decided to rescind federal protections for those operating within state-sanctioned cannabis industries. (6-1)
This News Release is Not for Dissemination in The United States or for Distribution to United States Newswire Services (4-0)
TORONTO, ONTARIO--(Marketwired - Nov. 3, 2017) - The Canadian Bioceutical Corporation has announced a name change to MPX Bioceutical Corporation. Shares will begin trading under the new name and symbol on November 6, 2017. (4-0)
THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES (4-0)
Investors love Canadian pot companies but many plan to expand to the U.S. where marijuana legalization is a non-starter at the federal level. This puts the Toronto Stock Exchange in a bind.
A participant practices rolling a joint at the Cannabis Carnivalus 4/20 event in Seattle, April 20, 2014. — Reuters picNEW YORK, July 28 — Canada’s stock market has been ablaze with reefer madness, but the country’s largest exchange is grappling with how to deal with pot companies that have investments in the US, where marijuana is still banned by federal law.
TORONTO, ONTARIO--(Marketwired - April 18, 2017) - The Canadian Securities Exchange (CSE or the Exchange) announced results for the first quarter of 2017 today showing exceptional year-on-year growth in share turnover, value traded and the total value of financings completed by CSE listed companies. The exchange also welcomed 12 new listed companies during the quarter and co-hosted events across Canada, noting a significant increase in investor interest as the operating environment for North American small-cap companies continued to strengthen.
TORONTO, ON / ACCESSWIRE / April 4, 2017 / The Canadian Bioceutical Corporation (the "Company" or "BCC") (CSE: BCC, OTC PINK: CBICF) today announces that the Company's press release announcing the Massachusetts acquisition, issued this morning, contains an error in that the sub-heading states the call is on April 4th. The correct date for the call is April 5th. The Company apologizes for the confusion and looks forward to speaking with investors on the call.
Early Mover Advantage in Legalized Adult Use Market First $9.5M Tranche of Private Placement Closed Conference Call to Discuss New Acquisition on April 4, 2017 at 10am ET
TORONTO, ON / ACCESSWIRE / April 3, 2017 / The Canadian Bioceutical Corporation (the "Company" or "BCC") (CSE: BCC, OTC PINK: CBICF) is pleased to announced that the Company has retained Echelon Wealth Partners Inc. ("Echelon") to assist BCC with assessing, structuring and negotiating mergers and acquisitions, and general corporate and financial advisory services, as well as introduce the Company to prospective investors. (0-1)
TORONTO, ON / ACCESSWIRE / March 30, 2017 / The Canadian Bioceutical Corporation (the "Company" or "BCC") (CSE: BCC, OTC: CBICF) today announced that it intends to raise up to US$20,000,000 in a private placement by issuing approximately 54,000,000 common shares in the capital of the Company at a price of CAD$0.50 per common share. The Company will determine the number of Common Shares issuable pursuant to the offering by deeming the United States dollar / Canadian dollar currency conversion rate applicable for the issuance of common shares prior to closing. (0-1)
TORONTO, ON / ACCESSWIRE / March 20, 2017 / The Canadian Bioceutical Corporation (the "Company" or "BCC") (CSE: BCC, OTC PINK: CBICF) is pleased to announced that effective March 17, 2017 at close of trading, the Company has been added to the CSE Composite Index. The index is comprised of shares of listed companies that meet market capitalisation, trading and seasoning criteria established by the exchange.
TORONTO, ON / ACCESSWIRE / March 6, 2017 / The Canadian Bioceutical Corporation (the "Company" or "BCC") (CSE: BCC, OTC PINK: CBICF) today announced that it has entered into a Market Making Services Agreement (the "Services Agreement") with Venture Liquidity Providers Inc. ("VLP") for an initial 12 month term.
The Canadian Bioceutical Corporation (the "Company" or "BCC") (CSE: BCC, OTC PINK: CBICF) today its financial results for the three and nine month periods ending December 31, 2016. Detailed financial statements and the Company's management discussion and analysis (MD&A) can be found on www.sedar.com
TORONTO, ON / ACCESSWIRE / February 6, 2017 / (CNSX: BCC) (OTC PINK: CBICF) The Canadian Bioceutical Corporation (the "Company" or "BCC") today announced that the Company has signed a letter of intent (LOI) to acquire the assets of PerkAZ Property LLC, an Arizona registered company active in the cannabis space. Completion of the transaction, subject to customary closing conditions, is anticipated within one week.